Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [01/16/2026 14:17 PST] Rapid Micro Biosystems, Inc. (NASDAQ:RPID), Up By 100% ($3.06) From $3.06 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [01/06/2026 07:31 PST] RPID Expected to Trade Up After Bullish Patterns Develop
• [01/05/2026 07:12 PST] RPID Expected to Trade Up After Bullish Patterns Develop
• [12/12/2025 10:29 PST] Rapid Micro Biosystems, Inc. (NASDAQ:RPID), Down By 100% ($4.11) From $4.11 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [11/25/2025 06:43 PST] RPID Expected to Trade Down After Bearish Patterns Develop